What is one of the objectives of the FDA Modernization Act?

The FDA Modernization Act primarily aims to update and clarify regulations surrounding the pharmaceutical industry, which includes compounding practices. One of its objectives is to provide clearer standards for compounding medications, ensuring that both pharmacists and manufacturers understand the legal framework they must operate within. By clarifying these standards, the Act helps to enhance the safety and efficacy of compounded medications, which are often tailored to meet the specific needs of patients. This clarification also assists in regulatory compliance, ultimately benefiting patients who rely on these customized medications.

The other options do not accurately reflect the primary objectives of the FDA Modernization Act. The Act does not focus on increasing patent protections, banning off-label information, or strictly limiting compounding to only FDA-approved manufacturers. Instead, it emphasizes establishing clear guidelines to support safe compounding practices while balancing patient access to necessary medications.